Overall Score

Revenue Growth

Revenue growth is not provided in the fresh data, so the growth trajectory remains unconfirmed.

The company still screens as a low-sales-multiple name at 0.50x price-to-sales and 0.66x EV/sales, which can support upside if growth stabilizes.

Profitability

Fresh margins remain weak, with EBIT margin at -4.6% and net margin at -7.4%.

Return metrics are still negative, including ROE at -14.1% and ROIC at -3.5%, indicating the business is not yet compounding capital effectively.

Financial Health

Liquidity remains solid with a current ratio of 2.84x and quick ratio of 1.67x.

Leverage is manageable at 0.55x debt-to-equity and 1.22x net debt-to-EBITDA, but interest coverage is still negative at -1.22x due to operating losses.

Cash Flow

Free cash flow remains negative, with free cash flow yield at -6.5% and free cash flow to firm also negative.

Operating cash flow is positive but thin relative to sales, with operating cash flow margin at 2.0% and capex still consuming a large share of operating cash flow.

Valuation

Valuation remains inexpensive on sales and book value, with price-to-sales at 0.50x and price-to-book at 0.99x.

However, the market is discounting weak earnings and cash generation, as shown by negative earnings yield and negative free cash flow yield.